INITIAL CLINICAL-TRIALS IN CANCER-PATIENTS OF POLYRIBOINOSINIC-POLYRIBOCYTIDYLIC ACID STABILIZED WITH POLY-L-LYSINE, IN CARBOXYMETHYLCELLULOSE [POLY(ICLC)], A HIGHLY EFFECTIVE INTERFERON INDUCER

This publication has 9 references indexed in Scilit:

• Human Leukocyte Interferon for the Treatment of Herpes Zoster in Patients with Cancer
  New England Journal of Medicine, 1978
• Antitumor Activity of Interferon Against Murine Osteogenic Sarcoma Cells In Vitro 2 3
  JNCI Journal of the National Cancer Institute, 1978
• Role of endogenous interferon in the anti‐tumor effect of poly I·C and statolon as demonstrated by the use of anti‐mouse interferon serum
  International Journal of Cancer, 1978
• Hyaluronic acid produced by human synovial fibroblasts. Effect of polyinosinic‐polycytidylic acid (POLY I:C) and interferon
  Arthritis & Rheumatism, 1976
• MODIFICATION OF CHRONIC HEPATITIS-B VIRUS INFECTION IN CHIMPANZEES BY ADMINISTRATION OF AN INTERFERON INDUCER
  The Lancet, 1976
• Effect of Human Leukocyte Interferon on Hepatitis B Virus Infection in Patients with Chronic Active Hepatitis
  New England Journal of Medicine, 1976
• A Phase I–II Trial of Multiple-Dose Polyriboinosinic-Polyribocytidylic Acid in Patients With Leukemia or Solid Tumors
  JNCI Journal of the National Cancer Institute, 1976
• A Modified Polyriboinosinic-Polyribocytidylic Acid Complex That Induces Interferon in Primates
  The Journal of Infectious Diseases, 1975
• Interferon induction and utilization
  Journal of Cellular Physiology, 1968